FDA approves Medtronic’s extravascular ICD for abnormal heart rhythms Posted on October 24th, 2023 by LEADconnection Post navigation Previous: Medtronic receives FDA approval for extravascular defibrillator to treat abnormal heart rhythms, sudden cardiac arrestNext: Impulse Dynamics Receives Full-Body MRI-Conditional Approval for Optimizer Smart Mini System
Earlier Extraction for Cardiac Device Infections Tied to Lower Mortality Posted on October 20th, 2023 by LEADconnection Post navigation Previous: Discussing the Prognosis and Complications of Transvenous Lead Extraction in Patients With Cardiac Implantable Electronic Devices (CIED): A Systematic ReviewNext: Medtronic receives FDA approval for extravascular defibrillator to treat abnormal heart rhythms, sudden cardiac arrest
New data hint at “hard to beat” efficacy and safety for rotational TLE Posted on September 6th, 2023 by LEADconnection Post navigation Previous: Minimizing Atrial Pacing No Benefit in Sinus Node Disease: DANPACE IINext: European TauroPace Registry – University of Schleswig-Holstein Prospective Observational Clinical Study (ETPR)